ECSP961892A - PROCEDURES FOR INHIBITING THE PLASMINOGEN ACTIVATOR INHIBITOR 1 - Google Patents
PROCEDURES FOR INHIBITING THE PLASMINOGEN ACTIVATOR INHIBITOR 1Info
- Publication number
- ECSP961892A ECSP961892A ECSP961892A ECSP961892A EC SP961892 A ECSP961892 A EC SP961892A EC SP961892 A ECSP961892 A EC SP961892A EC SP961892 A ECSP961892 A EC SP961892A
- Authority
- EC
- Ecuador
- Prior art keywords
- plasminogen activator
- inhibiting
- activator inhibitor
- procedures
- hexamethyleneimino
- Prior art date
Links
- 102000012335 Plasminogen Activator Inhibitor 1 Human genes 0.000 title abstract 2
- 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 title abstract 2
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- -1 pyrrolidino, hexamethyleneimino Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Landscapes
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se refiere a un procedimiento para inhibir el inhibidor del activador del plasminógeno 1 que comprende administrar a un humano en su necesidad una cantidad eficaz de un compuesto de fórmula en la que R1 y R3 son independientemente hidrógeno- CH3, -C-(alquilo de C1-C6), o -C-Ar, en el que Ar es fenilo opcionalmente sustituido; R2 se selecciona entre el grupo compuesto por pirrolidino, hexametilenimino y piperidino; o una de sus sales o solvatos farmacéuticamente aceptables.It refers to a method of inhibiting plasminogen activator inhibitor 1 which comprises administering to a human in need an effective amount of a compound of formula wherein R1 and R3 are independently hydrogen-CH3, -C- (C1-alkyl -C6), or -C-Ar, where Ar is optionally substituted phenyl; R2 is selected from the group consisting of pyrrolidino, hexamethyleneimino and piperidino; or one of its pharmaceutically acceptable salts or solvates.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP961892 ECSP961892A (en) | 1996-10-08 | 1996-10-08 | PROCEDURES FOR INHIBITING THE PLASMINOGEN ACTIVATOR INHIBITOR 1 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP961892 ECSP961892A (en) | 1996-10-08 | 1996-10-08 | PROCEDURES FOR INHIBITING THE PLASMINOGEN ACTIVATOR INHIBITOR 1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP961892A true ECSP961892A (en) | 1997-10-17 |
Family
ID=42042618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP961892 ECSP961892A (en) | 1996-10-08 | 1996-10-08 | PROCEDURES FOR INHIBITING THE PLASMINOGEN ACTIVATOR INHIBITOR 1 |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP961892A (en) |
-
1996
- 1996-10-08 EC ECSP961892 patent/ECSP961892A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20005237L (en) | Heterocyclic substituted amides used as calpain inhibitors | |
| ES2160640T3 (en) | NEW (R) -5-CARBAMOIL-8-FLUORO-3-AMINO DISSTITUTED IN N, N-3,4-DIHIDRO-2H-1-BENZOPIRANOS. | |
| TR199801151T2 (en) | Drugs that inhibit thrombin. | |
| NO992492L (en) | Benzamidoaldehydes and their use as cysteine protease inhibitors | |
| RU94045846A (en) | Use of benzothiophene derivatives for thrombin inhibition | |
| AR009020A1 (en) | PROTEASE INHIBITORS | |
| ES2101449T3 (en) | INHIBITION OF SEBORRHEA AND ACNE. | |
| AR029145A1 (en) | COMPOSITE OF REPLACED PIRROLIDINE HYDROXAMATE, METALOPROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND USE TO PREPARE A PHARMACEUTICAL COMPOSITION | |
| ES2119094T3 (en) | INHIBITION OF DYSFUNCTIONAL UTERINE HEMORRHAGE. | |
| BR9916255A (en) | Compound, pharmaceutical composition, use of a compound, and methods of treating a condition in which thrombin inhibition is required and for the preparation of compounds | |
| UY24425A1 (en) | THIOL DERIVATIVES WITH METALOPEPTIDASE INHIBITOR ACTIVITY. | |
| CO4750819A1 (en) | PROCEDURES FOR INHIBITING THE PLASMINOGEN ACTIVATOR INHIBITOR 1 | |
| DE69625505D1 (en) | GUANIDINO PROTEIASE INHIBITORS | |
| CO4650039A1 (en) | BENZOTHIOPHENES AMORPHOS, PREPARATION PROCEDURES AND USE PROCEDURES | |
| ES2182090T3 (en) | NEW DERIVATIVES OF PIRROL. | |
| CO5280088A1 (en) | PROTEASA INHIBITORS | |
| ECSP961892A (en) | PROCEDURES FOR INHIBITING THE PLASMINOGEN ACTIVATOR INHIBITOR 1 | |
| UY26329A1 (en) | VITRONECTIN RECEPTOR ANTAGONISTS | |
| MX9702148A (en) | Methods of inhibiting endometrial mitoses. | |
| CO4290297A1 (en) | INDOL DERIVATIVES THAT HAVE INHIBITING ACTIVITY OF ESTE- ROIDE 5 ALFA-REDUCTASAS | |
| ES2195313T3 (en) | IMINO-AZA-ANTHRACICLINONE DERIVATIVES FOR THE TREATMENT OF AMYLOIDOSIS. | |
| MX9701327A (en) | METHODS TO INHIBIT ENDOMETRIAL CANCER. | |
| MX9701332A (en) | METHODS TO CURE AND REPAIR BONE FRACTURES. | |
| ECSP972009A (en) | PROCEDURES TO INHIBIT COLUMAN TUMORS | |
| MX9704035A (en) | Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof. |